The Beck Depression Inventory-II (BDI-II) is a copyrighted, 21-item self-report questionnaire that measures the severity of depressive symptoms in adults and adolescents aged 13 and older. Developed by Aaron Beck and colleagues in 1996, it asks respondents to rate how they have felt over the past two weeks and produces a single severity score.
Why healthcare providers use the BDI-II
- Symptom severity in one number. It condenses 21 symptom ratings into a single 0 to 63 score that clinicians can interpret at a glance.
- Progress tracking. Because it asks about the past two weeks, it can be repeated to show whether symptoms are improving or worsening across visits.
- Widely validated. Decades of peer-reviewed research support its reliability and validity across clinical and research populations.
- Patient self-report. Patients complete it themselves, capturing their own experience of mood, cognition, and physical symptoms.
Which settings use the BDI-II?
- Psychiatry and behavioral health. Clinicians use it at intake and throughout treatment to gauge depression severity.
- Primary care. Providers use it to quantify symptoms when depression is suspected or being monitored.
- Research settings. Investigators use it as a standardized outcome measure in clinical trials and studies.
- Inpatient and specialty programs. Care teams track symptom change during intensive or step-down treatment.
What does the BDI-II measure?
The BDI-II assesses the severity of depressive symptoms experienced over the previous two weeks. Its 21 items align with common criteria for depression and span emotional, cognitive, and physical experiences. Because the instrument is copyrighted, the item wording is not reproduced here; the domains below describe the areas it covers.
- Emotional symptoms. Sadness, loss of pleasure, guilt, and irritability.
- Cognitive symptoms. Pessimism, self-criticism, worthlessness, indecisiveness, and thoughts of self-harm.
- Physical and somatic symptoms. Changes in sleep, appetite, energy, and concentration.
- Motivational symptoms. Loss of interest and reduced ability to work or engage in activities.
Scoring the BDI-II
- Number of items. 21 items, each describing a depression-related symptom.
- Per-item scale. Each item is rated from 0 to 3, reflecting increasing severity.
- Total score range. Item ratings are summed for a total from 0 to 63.
- Score direction. Higher totals indicate more severe depressive symptoms.
The BDI-II is a screening and severity measure, not a diagnostic test. Scores should be interpreted alongside a clinical interview and history, and results can be affected by physical illness, other conditions, or how the patient understands the items. The severity ranges below come from the BDI-II manual and guide clinical decision-making rather than dictate it.
| Score | Interpretation | Suggested next step |
|---|---|---|
| 0-13 | Minimal depressive symptoms | Monitor |
| 14-19 | Mild depressive symptoms | Watchful waiting |
| 20-28 | Moderate depressive symptoms | Consider further assessment |
| 29-63 | Severe depressive symptoms | Consider prompt further evaluation |
Best practices for administration
- Confirm licensing. Ensure your practice holds a valid license from the publisher before administering the BDI-II.
- Use a consistent time frame. Ask patients to rate the past two weeks each time so scores stay comparable.
- Provide a private setting. Let patients complete it somewhere they feel comfortable answering honestly.
- Review responses promptly. Check for any item indicating self-harm and act on it regardless of the total score.
- Repeat at intervals. Re-administer on a schedule to track change during treatment.
- Interpret in context. Combine the score with clinical judgment and the patient's history.
How Zentake helps with the BDI-II
- Automatic scoring. Totals calculated on submit, no hand-tallying.
- Longitudinal tracking. Re-send on a schedule and view change over time.
- Risk flagging. Concerning responses surfaced to staff.
- Before the visit. Patients complete it from home on any device so mental health practices start informed.
- HIPAA compliant. Encrypted, signed BAA on every plan.
References
The BDI-II was introduced by Beck AT, Steer RA, and Brown GK in the Manual for the Beck Depression Inventory-Second Edition (San Antonio, TX: Psychological Corporation, 1996). The instrument is copyrighted and published by Pearson, which licenses its use.
The severity ranges cited here (minimal 0 to 13, mild 14 to 19, moderate 20 to 28, severe 29 to 63) are drawn from the BDI-II manual and are summarized in the NINDS Common Data Elements reference for the BDI-II.
Last updated: August 2026